Modelling risk assessment for cervical cancer in symptomatic Saudi women
Objectives: To assess whether the utility of cervical cancer screening could be improved by combining multiple factors in addition to the pap test.
Methods: A retrospective cohort study of 300 symptomatic women who were suspected to have cervical cancer and referred for biopsy examination at King Abdulaziz Medical City, Riyadh, Saudi Arabia between February 2017 and December 2017.
Results: A high risk of cervical cancer in Saudi women was associated with 4 risk factors: family history (adjusted odds ratio [aOR], 4.216; 95% confidence intervals [CI], 1.433–12.400), vaginal bleeding (aOR, 3.959; 95% CI, 1.272–12.318), hypertension (aOR, 4.554; 95% CI, 1.606–12.912), and an abnormal pap smear test (aOR, 13.985; 95% CI, 5.108–38.284). The model yields an adequate utility (area under the curve, 87.5%, 95% CI, 80.9-94.0%) with acceptable goodness-of-fit (p=0.6915).
Conclusion: The pap smear test alone is inadequate to assess high risk for cervical cancer in our center. Early detection of cervical cancer may require consideration of a combination of factors including the pap test. This study has shown that using a combination of abnormal family history, vaginal bleeding, hypertension, and the pap smear test improved the effectiveness of cervical cancer screening.
Saudi Med J 2019; Vol. 40 (5): 447-451
How to cite this article:
Al-Madani W, Ahmed AE, Arabi H, Al Khodairy S, Al Mutairi N, Jazieh AR. Modelling risk assessment for cervical cancer in symptomatic Saudi women. Saudi Med J. 2019 May;40(5):447-451. doi: 10.15537/smj.2019.5.24085.
Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011; 22: 2675-2686.
Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893-1907.
Alhamlan FS, Al-Qahtani AA, Al-Ahdal MN. Current studies on human papillomavirus in Saudi Arabia. J Infect Deve Ctries 2015; 9: 571-576.
Munoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
Al-Darwish AA, Al-Naim AF, Al-Mulhim KS, Al-Otaibi NK, Moris MS, Aleem AM. Knowledge about cervical cancer early warning signs and symptoms, risk factors and vaccination among students at a medical school in Al-Ahsa, Kingdom of Saudi Arabia. Asian Pac Jof Cancer Prev 2014; 15: 2529-2532.
Szostek S, Klimek M, Zawilinska B, Kosz-Vnenchak M. Genotype-specific human papillomavirus detection in cervical smears. Acta Biochim Pol 2008; 55: 687-692.
Walboomers JM, Jacob MV, Manos MM, Bosch FX, Kummar JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
Sehgal A, Singh V. Human papillomavirus infection (HPV) & screening strategies for cervical cancer. Indian J Med Res 2009; 130: 234-240.
Moyer VA, U.S. Preventive Task Force. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 156: 880-891.
Chen C, Yang Z, Li Z, Li L. Accuracy of several cervical screening strategies for early detection of cervical cancer: a meta-analysis. Int J Gynecol Cancer 2012; 22: 908-921.
National Institutes of Health. Cervical cancer: NIH consensus statement. Bethesda: National Institutes of Health. 1996. p. 1-38.
Ferri FF. Ferri’s Netter Patient Advisor. [Updated 2016 January 28th]. Available from: https://www.elsevier.com/books/ferris-netter-patient-advisor/ferri/978-0-323-39324-9
Zhao L, Wentzensen N, Zhang RR, Dunn ST, Gold MA, Wang SS, et al. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer. Cancer Cytopathol 2014; 122: 694-701.
Nasser H, AlAyyaf M, Atallah A, Aminulislam M, Rizwan L, Aodah A, et al. Eleven-year review of data on pap smears in Saudi Arabia: we need more focus on glandular abnormalities!. Ann Saudi Med 2017; 37: 265-271.
Cardenas-Turanzas M, Follen M, Nogueras-Gonzalez GM, Benedet JL, Beck JR, Cantor SB. The accuracy of the Papanicolaou smear in the screening and diagnostic settings. Journal of Lower Genital Tract Disease 2008; 12: 269-275.
Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387.
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32-35.
Ahmed AE, Alzahrani FS, Gharawi AM, Alammary SA, Almijmaj FH, Alhusayni FM, et al. Improving risk prediction for pancreatic cancer in symptomatic patients: a Saudi Arabian study. Cancer Manag Res 2018; 10: 4981-4986.
Ahmed AE, McClish DK, Alghamdi T, Alshehri A, Aljahdali Y, Aburayah K, et al. Modeling risk assessment for breast cancer in symptomatic women: a Saudi Arabian study. Cancer Manag Res 2019;11: 1125-1132.
Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Seattle. (WA): IHME, University of Washington; 2016.
Lacey Jr JV, Swanson CA, Brinton LA, Altekruse SF, Barnes WA, Gravitt PE, et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003; 98: 814-821.
Nappi L, Indraccolo U, Sardo AD, Gentile G, Palombino K, Castaldi MA, et al. Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps? J Minim Invasive Gynecol 2009; 16: 157-162.
Oberaigner W, Ebenbichler C, Oberaigner K, Juchum M, Schönherr HR, Lechleitner M. Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria. BMC Public Health 2014; 14: 1058.
DiSaia PJ, Chaudhuri G, Giudice LC, Moore TR, Smith LH, Porto MM. Women’s health review: a clinical update in obstetrics-gynecology. 1st ed. Philadelphia; Saunders/Elsevier; 2012.
Almughais ES, Alfarhan A, Salam M. Awareness of primary health care physicians about human papilloma virus infection and its vaccination: a cross-sectional survey from multiple clinics in Saudi Arabia. Infect Drug Resist 2018; 11: 2257-2267.
- There are currently no refbacks.
Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention. Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.